Facebook Pixel Code

Venus Remedies Share Price

NSE
BSE

VENUS REMEDIES

Sector : Pharmaceuticals and health care | Smallcap | BSE

Here's the live share price of Venus Remedies along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹428.00
-1.62₹ -7.05
As on Sep 19, 2025, 2:09 PM IST
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Venus Remedies Price Performance

Today's LowToday's High
₹428.00₹439.15
₹428.00
52 Weeks' Low52 Weeks' High
₹272.20₹565.95
₹428.00
Open Price
₹435.05
Prev. Close
₹435.05
Volume
1,278

Over the last 5 years, the share price of Venus Remedies has gained 24.98% CAGR. Over the past year, the corresponding return has been 24.45%.

Venus Remedies’s current P/E of 10.65x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.

Venus Remedies Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Venus Remedies
-5.47-9.980.2645.0424.4523.6924.98
Sun Pharmaceutical Industries
2.832.200.89-4.12-9.9923.8726.97
Divi's Laboratories
3.002.05-4.406.7114.2019.7014.46
Cipla
-0.591.005.484.40-4.5214.7715.30
Torrent Pharmaceuticals
1.58-0.7614.3513.478.1134.7921.79
Dr. Reddy's Laboratories
0.356.08-0.4112.721.5117.245.15
Mankind Pharma
2.335.9613.6622.148.6022.8513.14
Zydus Lifesciences
-0.555.079.4014.24-1.4542.4221.27
Lupin
0.554.366.29-0.33-5.3547.3914.56
Alkem Laboratories
1.292.3615.4813.69-10.1219.3414.00
Abbott India
-0.27-6.60-0.431.8010.4321.1014.21
Aurobindo Pharma
2.683.093.76-3.41-26.4129.327.28
Glenmark Pharmaceuticals
-1.587.7627.8741.0627.0078.1934.68
Laurus Labs
4.545.8645.0054.5599.1722.6626.83
Biocon
1.211.516.008.142.438.40-2.94
Anthem Biosciences
1.293.1715.5715.5715.574.942.94
GlaxoSmithKline Pharmaceuticals
-0.92-2.42-13.92-3.031.8724.9010.16
Cohance Lifesciences
-6.81-0.56-7.50-21.23-22.3625.7819.28
Ipca Laboratories
3.59-1.710.080.46-6.3116.675.51
Gland Pharma
-0.113.7818.1627.5411.50-3.482.09

Over the last one year, Venus Remedies has gained 24.45% compared to peers like Sun Pharmaceutical Industries (-9.99%), Divi's Laboratories (14.20%), Cipla (-4.52%). From a 5 year perspective, Venus Remedies has outperformed peers relative to Sun Pharmaceutical Industries (26.97%) and Divi's Laboratories (14.46%).

Venus Remedies Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Venus Remedies Stock Technicals

Moving Average

DaySMAEMA
5450.24449.94
10455.83455.2
20466.43463.94
50486.23466.64
100438.46440.96
200373.79402.5

Venus Remedies Share Holding Pattern

In the latest quarter, Venus Remedies remained same as its previous close in promoter holding, while DII stake increased to 0.11%, FII holding rose to 2.25%, and public shareholding moved down to 55.89% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Venus Remedies Corporate Actions

Date Time
Announcement
Sep 11, 2025, 5:17 PM ISTVenus Remedies L - Social Media Post On Saksham Niveshak Campaign By IEPF.
Aug 27, 2025, 3:29 PM ISTVenus Remedies L - Social Media Communication Regarding Special Window For Re-Lodgement Of Transfer Requests Of Physical Shar
Aug 23, 2025, 9:55 PM ISTVenus Remedies L - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Aug 23, 2025, 5:18 PM ISTVenus Remedies L - Special Window For Re-Lodgement Of Transfer Requests OfPhysical Shares - Report For July 2025
Aug 23, 2025, 5:10 PM ISTVenus Remedies L - Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares - Report For July 2025

About Venus Remedies

Venus Remedies Ltd. is a Public Limited Listed company incorporated on 15/09/1989 and has its registered office in the State of Chandigarh, India. Company's Corporate Identification Number(CIN) is L24232CH1989PLC009705 and registration number is 009705. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 639.46 Cr. and Equity Capital is Rs. 13.37 Cr. for the Year ended 31/03/2025.

Management

  • Mr. Pawan Chaudhary
    Chairman & Managing Director
  • Dr.(Mrs.) Manu Chaudhary
    Joint Managing Director
  • Mr. Peeyush Jain
    Deputy Managing Director
  • Mr. Ashutosh Jain
    Executive Director
  • Mr. Akshansh Chaudhary
    Executive Director
  • Dr.(Mrs.) Savita Gupta
    Independent Director
  • Mr. N P S Monga
    Independent Director
  • Mr. Navdeep Sud
    Independent Director
  • Mr. Jagdish Chander Sharma
    Independent Director
  • Dr. Anil Kumar
    Independent Director

FAQs on Venus Remedies Share Price

What is the share price of Venus Remedies?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Venus Remedies is ₹428.00 as on Sep 19, 2025.

What kind of stock is Venus Remedies?

The Venus Remedies is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.

What is the Market Cap of Venus Remedies?

The market cap of Venus Remedies is ₹572.11 Cr as on Sep 19, 2025.

What are today's High and Low prices of Venus Remedies?

Today’s highest and lowest price of Venus Remedies are ₹439.15 and ₹428.00.

What are the 52 Week High and 52 Week Low of Venus Remedies?

The 52-week high/low is the highest and lowest price at which Venus Remedies stock has traded in the past 52-week or nearly a year. The 52-week high of Venus Remedies is ₹565.95 and 52-week low of Venus Remedies is ₹272.20 as on Sep 19, 2025.

How has the Venus Remedies performed historically in terms of returns?

The Venus Remedies has shown returns of -1.62% over the past day, -9.98% for the past month, 0.26% over 3 months, 24.45% over 1 year, 23.69% across 3 years, and 24.98% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Venus Remedies?

P/E ratio of and PB ratio of Venus Remedies are 10.65 and 1.16 on Sep 19, 2025. While the company gives a dividend yield of 0.00 per annum.

icon
Market Data